Related Experiment Video
Updated: May 31, 2025
08:41
Live Imaging and Quantification of Viral Infection in K18 hACE2 Transgenic Mice Using Reporter-Expressing Recombinant SARS-CoV-2
Published on: November 5, 2021
2.7K
SARS-CoV-2 Evolution: Implications for Diagnosis, Treatment, Vaccine Effectiveness and Development
Fabrizio Angius1, Silvia Puxeddu1, Silvio Zaimi1
1Microbiology and Virology Unit, Department of Biomedical Sciences, University of Cagliari, University Campus, 09042 Monserrato, Italy.
Vaccines
|January 24, 2025
Summary
The SARS-CoV-2 virus rapidly evolves, impacting COVID-19 vaccine effectiveness and treatments. Continued research and adaptive strategies are crucial to combat ongoing viral evolution and protect public health.
Area of Science:
- Virology
- Immunology
- Public Health
Background:
- The COVID-19 pandemic, caused by the SARS-CoV-2 virus, continues to pose global health challenges due to rapid viral evolution.
- Mutations, particularly in the spike protein, affect transmissibility, immune evasion, and vaccine efficacy, leading to recurrent waves of infection and mortality.
Purpose of the Study:
- To comprehensively analyze the functional impact of SARS-CoV-2 mutations on diagnostic accuracy, therapeutic effectiveness, and vaccine efficacy.
- To review vaccine safety during pregnancy and the role of hybrid immunity in long-term protection.
- To discuss advancements in pan-coronavirus vaccines and nasal formulations.
Main Methods:
- Literature review and synthesis of current research on SARS-CoV-2 evolution and its implications.
- Analysis of data on viral mutations, vaccine effectiveness, and treatment outcomes.
- Discussion of emerging vaccine technologies and public health strategies.
Main Results:
- Viral mutations significantly influence diagnostic test reliability, antiviral drug efficacy, and the effectiveness of existing vaccines.
- Hybrid immunity offers potential for enhanced and prolonged protection against SARS-CoV-2 infection.
- New vaccine candidates, including pan-coronavirus and nasal spray formulations, show promise for future pandemic preparedness.
Conclusions:
- Ongoing SARS-CoV-2 evolution necessitates continuous genomic surveillance and adaptive public health responses.
- Understanding mutation impacts is vital for developing next-generation vaccines and therapeutics.
- Further research into vaccine safety, hybrid immunity, and novel delivery methods is essential for long-term COVID-19 control.
Related Concept Videos
01:05Single Nucleotide Polymorphisms-SNPs
13.9K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
13.9K
00:36Viral Mutations
32.1K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.1K